πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 1,641 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 8211891

Difluoromethyl-containing macrocyclic compounds as hepatitis C virus inhibitors

Enanta Pharmaceuticals, Inc. Β· Granted Tue Jul 03 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 28 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8202844

Indole antiviral compositions and methods

THE REGENTS OF THE UNIVERSITY OF MICHIGAN Β· Granted Tue Jun 19 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 14 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8193152

Treatment or prevention of hemorrhagic viral infections with immunomodulator compounds

The Board of Regents of the University of Texas System Β· Granted Tue Jun 05 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 31 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8187872

Lentiviral vectors pseudotyped with a sindbis virus envelope glycoprotein

IMMUNE DESIGN CORP. Β· Granted Tue May 29 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 24 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8183358

Puumala virus full-length M segment-based DNA vaccines

The United States of America as represented by the Secretary of the Army Β· Granted Tue May 22 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 17 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8178531

Antiviral agents

Enanta Pharmaceuticals, Inc. Β· Granted Tue May 15 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 10 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8173362

Cytomegalovirus surface protein complex for use in vaccines and as a drug target

THE TRUSTEES OF PRINCETON UNIVERSITY Β· Granted Tue May 08 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 03 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8168604

Antisense antiviral compounds and methods for treating a filovirus infection

The United States of America as represented by the Army Medical Research and Material Command Β· Granted Tue May 01 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8168202

Hexavalent bovine rotavirus reassortant composition designed for use in developing countri

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue May 01 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8168200

Vaccine against african horse sickness virus

The Regents of the University of California Β· Granted Tue May 01 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8163548

Recombinant bicistronic flaviviruses and methods of use thereof

The Regents of the University of California Β· Granted Tue Apr 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8163545

Vaccine against pandemic strains of influenza viruses

The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention Β· Granted Tue Apr 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8163893

Pseudotyped retroviral vectors and methods of use thereof

The Regents of the University of California Β· Granted Tue Apr 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8158677

Treatment of viral infections by modulation of host cell metabolic pathways

THE TRUSTEES OF PRINCETON UNIVERSITY Β· Granted Tue Apr 17 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 12 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8158675

Compounds and methods for the treatment or prevention of Flavivirus infections

Vertex Pharmaceuticals (Canada) Incorporated Β· Granted Tue Apr 17 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 12 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8147840

Human immunodeficiency virus (HIV) immunization strategies employing conformationally-stab

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Apr 03 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8147845

Reovirus clearance of ras-mediated neoplastic cells from mixed cellular compositions

ONCOLYTICS BIOTECH INC. Β· Granted Tue Apr 03 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8137960

Bovine adeno-associated viral (BAAV) vector and uses thereof

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Mar 20 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 15 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8133495

Live attenuated antigenically marked classical swine fever virus

The United States of America, as represented by the Secretary of Agriculture Β· Granted Tue Mar 13 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 08 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8124592

Development of a preventive vaccine for filovirus infection in primates

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Feb 28 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 23 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8124105

Compositions, methods and kits relating to poxvirus subunit vaccines

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Feb 28 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 23 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8124101

Genetically engineered swine influenza virus and uses thereof

The United States of America, as represented by the Secretary of Agriculture Β· Granted Tue Feb 28 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 23 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8119656

Inhibitors of the influenza virus non-structural 1 protein

The Board of Regents of the University of Texas System Β· Granted Tue Feb 21 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 16 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8114852

N-linked glycosylation alteration in E1 glycoprotein of classical swine fever virus and no

The United States of America, as represented by the Secretary of Agriculture Β· Granted Tue Feb 14 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 09 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted